A systematic review and meta-analysis of randomized controlled head-to-head trials of recommended drugs for neuropathic pain.

Pain Rep · 2024 · PMC11208104 · PMID 38932764

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

a nonsignificant trendP = 0.08so close (0.05 < p ≤ 0.1)

The combined effect showed a nonsignificant trend, suggesting superiority of TCA compared with pregabalin/gabapentin (RD 0.06, 95% Cl −0.01 to 0.12, P = 0.08). 3.3.1.3.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.